|
KC-ISHBT 2026 Scientific Program |
|
|
Time (IST) |
Sessions |
|
08:30 AM - 09:00 AM |
Registrations |
|
09:00 AM - 09:45 AM |
Quiz: Prelims For MD / DNB Residents Faculty: Dr Chaitanya H Balakrishnan, Dr Vandana Bharadwaj, Dr Madhupriya B, Dr Veronica Lobo, Dr Sushma B |
|
09:15 AM - 09:45 AM |
Session 1 |
|
09:15 AM - 09:30 AM |
Zanubrutinib: Next Gen BTKi for B-cell Lymphomas Faculty: Dr Seetharam Anandram |
|
09:30 AM - 09:45 AM |
Panel Discussion (Sponsored by Glenmark) Panelists: Dr Veronica Lobo, Dr Karthik RG, Dr Santosh Subramaniam, Dr Megala Chandrashekar |
|
09:45 AM - 10:20 AM |
Session 2 Chairperson: Dr Arun |
|
09:45 AM - 10:00 AM |
TTP: Early Diagnosis & Contemporary Mx Faculty: Dr Mahesh Rajashekaraiah |
|
10:00 AM - 10:20 AM |
Nivolumab in Hodgkin
Lymphoma: Changing The Treatment Paradigm Faculty: Dr Satish Kumar A |
|
10:20 AM - 11:00 AM |
Session 3 |
|
10:20 AM - 10:40 AM |
Changing The CMV Story: The
Letermovir Revolution Faculty: Dr Mallikarjun Kalashetty |
|
10:40 AM - 11:00 AM |
Optimal Sequencing For
Better Patient Outcome in CLL- Case Based Discussion Moderator: Dr Ashish Dixit |
|
11:00 AM - 11:15 AM |
TEA BREAK |
|
11:15 AM - 11:25 AM |
INAUGURATION |
|
11:25 AM - 12:15 PM |
Session 4 |
|
11:25 AM - 11:40 AM |
The Immunotherapy Revolution in ALL Faculty: Dr Rajesh Krishna |
|
11:40 AM - 11:55 AM |
The Essential Non-Technical Skills in Haematology Faculty: Dr Vandana Bharadwaj |
|
11:55 AM - 12:15 PM |
The Role of Anti-BCMA
Therapies in the Management of Myeloma Faculty: Dr Revanth Boddu |
|
12:15 PM - 01:10 PM |
Session 5 |
|
12:15 PM - 12:30 PM |
Flow Cytometry: Principles, Applications & Interpretation Faculty: Dr Jayashree Kulkarni |
|
12:30 PM - 12:45 PM |
Flow Cytometry - Based MRD in CLL: Interpretation in Clinical Practice Faculty: Dr Deepak MB |
|
12:45 PM - 01:10 PM |
Panel Discussion: HLH: Recognition & Treatment Strategies Moderator: Dr Intezar Mehdi |
|
01:10 PM - 01:45 PM |
LUNCH BREAK |
|
01:45 PM - 02:55 PM |
Session 6 |
|
01:45 PM - 02:05 PM |
Tackling the Challenges of Inflammation and Fibrosis in Chronic GVHD Faculty: Dr Mallikarjun Kalashetty |
|
02:05 PM - 02:25 PM |
Panel
Discussion Moderator: Dr Sharath Damodar |
|
02:25 PM - 02:55 PM |
BrECADD HD21 - The New
Benchmark in Advanced Lymphoma Faculty: Dr Natraj KS |
|
02:55 PM - 03:35 PM |
Session 7 |
|
02:55 PM - 03:20 PM |
IDH-1 Mutated AML in 2026:
Evidence, Experience & Evolving Perspectives Moderator: Dr Natraj KS |
|
03:20 PM - 03:35 PM |
MRD in AML: When, Where and
How? Faculty: Dr Ram |
|
03:35 PM - 04:05 PM |
TEA BREAK |
|
03:35 PM - 04:05 PM |
Quiz For Dr NB Residents Faculty: Dr Chaitanya H Balakrishnan, Dr Vandana Bharadwaj, Dr Madhupriya B, Dr Veronica Lobo, Dr Sushma B |
|
04:05 PM - 04:45 PM |
Session 8 |
|
04:05 PM - 04:30 PM |
Haemophilia in 2026: From Factor Replacement to Gene Therapy Moderator: Dr Alok Srivastava |
|
04:30 PM - 04:45 PM |
ITP management in 2026:
Current Standards And Emerging Therapies Faculty: Dr Chaitanya H Balakrishnan |
|
04:45 PM - 05:25 PM |
Session 9 |
|
04:45 PM - 05:10 PM |
Frontline Management of Paediatric Hodgkins Lymphoma: Current Standards & Emerging Strategies Moderator: Dr Sidharth Totadri |
|
05:10 PM - 05:25 PM |
NGS in Myeloma: Ready For
Prime Time Faculty: Dr Suruchi |
|
05:25 PM - 06:15 PM |
Quiz For MD/DNB Residents Faculty: Dr Chaitanya H Balakrishnan, Dr Vandana Bharadwaj, Dr Madhupriya B, Dr Veronica Lobo, Dr Sushma B |
|
06:15 PM - 06:45 PM |
Session 10 |
|
Annual General Body Meeting |
|
|
06:45 PM - 07:45 PM |
Session 11 |
|
06:45 PM - 07:45 PM |
Panel Discussion:
Sequencing BCMA Therapies: Who is The Right Patient? Dual Target, New Possibilities: BCMA
& GPRC5D in RRMM Moderator: Dr Sharat Damodar |